Volunteers flock to Phase II trials for Israel’s BriLife COVID-19 vaccine
Quest for homegrown vaccine continues even as country races to inoculate millions with Pfizer-BioNTech, Moderna shots.
Photo of Prof. Zeev Rotstein, head of Hadassah-University Medical Center, being screened for eligibility to be vaccinated on Monday as part of the Phase II trial of the Israeli vaccine candidate Brilife. December 20, 2020(photo credit: HADASSAH)ByMAYA MARGIT/THE MEDIA LINE
